The genetic variant can interfere with the activation of hormones
Proper storage preserves medication potency
Sinai Hospital and the University of Toronto in Toronto, Canada, is being recognized for having made seminal contributions to our understanding of the physiology and pharmacology of glucagon-like peptides (GLPs) and their use for the benefit of patients. His discoveries of GLP-1, GLP-2, and dipeptidyl peptidase-4 (DPP-4) activity have enabled the development of multiple new innovative classes of medications for the treatment of diabetes, obesity, and obesity-associated comorbidities
Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation
Hoekstra, A
IGF-1 mediates many of growth hormones anabolic effects, including muscle protein synthesis, bone growth, cartilage formation, and cellular proliferation